Table 1.
Characteristics of 215 HCT recipients in study cohort
| Characteristic | RhV or HCoV (n = 64), n (%) | No RhV or HCoV (n = 151), n (%) | All patients (n = 215), n (%) |
|---|---|---|---|
| Median age, y (range) | 50.2 (0.8-72.2) | 51.6 (0.6-72.2) | 51.2 (0.6-72.2) |
| No. of patients age < 12 y | 4 (6) | 5 (2) | 9 (4) |
| Sex | |||
| Female | 27 (42) | 58 (38) | 85 (40) |
| Male | 37 (58) | 93 (62) | 130 (60) |
| Underlying disease risk | |||
| Low | 6 (10) | 7 (5) | 13 (6) |
| Intermediate | 39 (60) | 103 (68) | 142 (66) |
| High | 19 (30) | 41 (27) | 60 (28) |
| Stem cell source | |||
| Bone marrow | 7 (11) | 21 (14) | 28 (14) |
| Peripheral blood | 53 (83) | 120 (79) | 173 (80) |
| Cord blood | 4 (6) | 10 (7) | 14 (7) |
| CMV serostatus | |||
| D+/R+ | 17 (27) | 35 (23) | 52 (24) |
| D+/R− | 8 (13) | 7 (4) | 15 (7) |
| D−/R+ | 20 (31) | 57 (38) | 77 (36) |
| D−/R− | 19 (29) | 52 (35) | 71 (33) |
| Donor match | |||
| Related-matched | 22 (34) | 52 (34) | 74 (34) |
| Related-mismatched | 4 (6) | 6 (4) | 10 (5) |
| Unrelated-matched | 28 (44) | 66 (44) | 94 (44) |
| Unrelated-mismatched | 10 (16) | 27 (18) | 37 (17) |
| Acute graft-versus-host disease | |||
| Grade 0 or 1 | 15 (23) | 43 (28) | 58 (27) |
| Grade 2-4 | 49 (77) | 108 (72) | 157 (73) |
| Transplantation type | |||
| Myeloablative | 32 (50) | 70 (46) | 102 (47) |
| Nonmyeloablative | 32 (50) | 81 (54) | 113 (53) |